From Pro, Anti to Informative and Hesitant: An Infoveillance study of COVID-19 vaccines and vaccination discourse on Twitter
Authors:
Pardeep Singh,
Rabindra Lamsal,
Monika Singh,
Satish Chand,
Bhawna Shishodia
Abstract:
COVID-19 pandemic has brought unprecedented challenges to the world, and vaccination has been a key strategy to combat the disease. Since Twitter is one of the most widely used public microblogging platforms, researchers have analysed COVID-19 vaccines and vaccination Twitter discourse to explore the conversational dynamics around the topic. While contributing to the crisis informatics literature,…
▽ More
COVID-19 pandemic has brought unprecedented challenges to the world, and vaccination has been a key strategy to combat the disease. Since Twitter is one of the most widely used public microblogging platforms, researchers have analysed COVID-19 vaccines and vaccination Twitter discourse to explore the conversational dynamics around the topic. While contributing to the crisis informatics literature, we curate a large-scale geotagged Twitter dataset, GeoCovaxTweets Extended, and explore the discourse through multiple spatiotemporal analyses. This dataset covers a longer time span of 38 months, from the announcement of the first vaccine to the availability of booster doses. Results show that 43.4% of the collected tweets, although containing phrases and keywords related to vaccines and vaccinations, were unrelated to the COVID-19 context. In total, 23.1% of the discussions on vaccines and vaccinations were classified as Pro, 16% as Hesitant, 11.4% as Anti, and 6.1% as Informative. The trend shifted towards Pro and Informative tweets globally as vaccination programs progressed, indicating a change in the public's perception of COVID-19 vaccines and vaccination. Furthermore, we explored the discourse based on account attributes, i.e., followers counts and tweet counts. Results show a significant pattern of discourse differences. Our findings highlight the potential of harnessing a large-scale geotagged Twitter dataset to understand global public health communication and to inform targeted interventions aimed at addressing vaccine hesitancy.
△ Less
Submitted 14 March, 2024;
originally announced March 2024.
GeoCovaxTweets: COVID-19 Vaccines and Vaccination-specific Global Geotagged Twitter Conversations
Authors:
Pardeep Singh,
Rabindra Lamsal,
Monika,
Satish Chand,
Bhawna Shishodia
Abstract:
Social media platforms provide actionable information during crises and pandemic outbreaks. The COVID-19 pandemic has imposed a chronic public health crisis worldwide, with experts considering vaccines as the ultimate prevention to achieve herd immunity against the virus. A proportion of people may turn to social media platforms to oppose vaccines and vaccination, hindering government efforts to e…
▽ More
Social media platforms provide actionable information during crises and pandemic outbreaks. The COVID-19 pandemic has imposed a chronic public health crisis worldwide, with experts considering vaccines as the ultimate prevention to achieve herd immunity against the virus. A proportion of people may turn to social media platforms to oppose vaccines and vaccination, hindering government efforts to eradicate the virus. This paper presents the COVID-19 vaccines and vaccination-specific global geotagged tweets dataset, GeoCovaxTweets, that contains more than 1.8 million tweets, with location information and longer temporal coverage, originating from 233 countries and territories between January 2020 and November 2022. The paper discusses the dataset's curation method and how it can be re-created locally, and later explores the dataset through multiple tweets distributions and briefly discusses its potential use cases. We anticipate that the dataset will assist the researchers in the crisis computing domain to explore the conversational dynamics of COVID-19 vaccines and vaccination Twitter discourse through numerous spatial and temporal dimensions concerning trends, shifts in opinions, misinformation, and anti-vaccination campaigns.
△ Less
Submitted 18 January, 2023;
originally announced January 2023.
